Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)
MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ -- Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that its Board of Directors approved a ratio change of its American Depository Shares (ADSs) to Ordinary Shares (the...
Premium Ski Goggles Exceed Industry Quality Standards During Testing
Outdoor Master is already an official supplier for the US Ski Team — r ely on its excellent quality and technology . SHENZHEN, China, Jan. 6, 2023 /PRNewswire/ -- A brand dedicated to providing high-quality outdoor gear at reasonable prices, Outdoor Master, reached a major milestone after exceeding a range of industry standards during the testing of its ski goggles....
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China’s first hormone replacement treatment targeting hypoparathyroidism
Submission of NDA to the NMPA is planned within 2023 at the earliest SHANGHAI, Jan. 6, 2023 /PRNewswire/ -- VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, announced today that it has completed the double-blind period of PaTHway China Trial, a phase 3 China clinical trial for its innovative investigational new prodrug palopegteriparatide on January 4, 2023,...
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
SYDNEY, Jan. 6, 2023 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today announced the extension of the backstopped rights offering to raise gross proceeds of approximately US$4.0 million (the "Rights Offering"). Under the terms of the Rights Offering, Parnell is extending the expiration date to Wednesday, January 11, 2023 at 5:00 PM (Eastern Time)...
CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vision of “Going for Zero” — Zero Heart Attacks and Zero Strokes
- "Viso," New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 - KYOTO, Japan, Jan. 6, 2023 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient-monitoring service to realize its "Going for Zero" vision to eliminate heart attack and stroke at the world's largest Consumer Electronic Show (CES 2023)....
Innovent Announces the National Medical Products Administration in China Has Accepted and Granted Priority Review Designation to the New Drug Application for Parsaclisib (PI3Kδ inhibitor) for the Treatment of...
ROCKVILLE, Md. and SUZHOU, China, Jan. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the New Drug Application (NDA) for parsaclisib (PI3Kδ inhibitor, R&D code: IBI376) for the treatment of adult...
SK Biopharmaceuticals CEO Donghoon Lee Buys 3,000 Shares of Company Stock
- CEO shows commitment and confidence in the company's future through share purchase PANGYO, South Korea, Jan. 6, 2023 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, today announced that Mr. Donghoon Lee, the Chief Executive Officer and President of SK Biopharmaceuticals and SK Life Science, has purchased 3,000 shares of...
WAYCEN, the first medical AI company to win 4 CES 2023 innovation awards “Proved K-Medtech”
Company specialized in AI Medtech, WAYCEN, won CES innovation awards for two years in a row WAYCEN swept CES 2023 innovation awards with medical AI products, collaborated with the medical staff SEOUL, South Korea, Jan. 6, 2023 /PRNewswire/ -- The company specialized in AI Medtech, WAYCEN (CEO Kyungnam Kim) made splendid achievements of winning four CES...
Kira to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference at 9:00 AM PT on Thursday, January 12, 2023. In...
Global Times: China shifts COVID policy with necessary conditions
BEIJING, Jan. 5, 2023 /PRNewswire/ -- After three years' hard efforts to keep COVID-19 at bay, China has optimized its virus response and come up with a major shift in its epidemic policy by downgrading COVID management and announcing the reopening of international borders from January 8, 2023. Global Times talked with frontline medical workers, experts and ordinary Chinese...
